THE UNIVERSITY OF KENTUCKY joined the TriNetX network for its clinical trial design and clinical research. Pharmaceutical researchers will gain access to the university’s clinical data through TriNetX’s network of healthcare institutions representing over 37 million patients in the U.S. and Europe to support clinical study and protocol design, site selection, and patient recruitment across...
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
